18 results
424B5
ABOS
Acumen Pharmaceuticals Inc
20 Jul 23
Prospectus supplement for primary offering
4:11pm
than 5% of our common stock;
persons who have elected to mark securities to market; and
persons holding our common stock as part of a hedging
424B5
ABOS
Acumen Pharmaceuticals Inc
17 Jul 23
Prospectus supplement for primary offering
4:49pm
common stock;
persons who have elected to mark securities to market; and
persons holding our common stock as part of a hedging or conversion transaction
424B5
38z33 bmhd1
27 Apr 23
Prospectus supplement for primary offering
7:06am
PRE 14A
jism 00dmsk
14 Apr 23
Preliminary proxy
4:33pm
S-3
mn0w71mi0s lflf6qe3
1 Jul 22
Shelf registration
5:06pm
DEF 14A
vcw09 u9va5tpbinhwk
27 Apr 22
Definitive proxy
5:03pm
10-K
frev1 8z0h555j6k
28 Mar 22
Annual report
4:51pm
10-Q
ifpgmtt
16 Aug 21
Quarterly report
4:51pm
424B4
q4eu56 814jgiko
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
EX-10.2
4s219uktb05ucx2dfy9d
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
65x66tt81m pv762
24 Jun 21
IPO registration (amended)
8:17am
S-1
h0m02i18o xj
9 Jun 21
IPO registration
5:02pm
DRS/A
2lxq1uv7srw 8i
14 May 21
Draft registration statement (amended)
12:00am
DRS
3im9veuqdx x497k8w64
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next